Browse the latest SEC filings and forms submitted by ALNYLAM PHARMACEUTICALS, INC. (ALNY). Access annual reports, quarterly statements, and other official disclosures.
View Insider Transactions for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
Search Company Filings →| Form | Filing Date | Description | Link |
|---|---|---|---|
| SCHEDULE 13G/A | March 26, 2026 | - | View Document |
| 4 | March 6, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 6, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 6, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 6, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 6, 2026 | PRIMARY DOCUMENT | View Document |
| 144 | March 5, 2026 | - | View Document |
| 144 | March 5, 2026 | - | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2026 | PRIMARY DOCUMENT | View Document |
| 8-K | March 4, 2026 | 8-K | View Document |
| 144 | March 3, 2026 | - | View Document |
| 144 | March 3, 2026 | - | View Document |
| 4 | March 2, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 2, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 2, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | March 2, 2026 | PRIMARY DOCUMENT | View Document |
| 144 | Feb. 27, 2026 | - | View Document |
| 4 | Feb. 25, 2026 | PRIMARY DOCUMENT | View Document |
| 144 | Feb. 17, 2026 | - | View Document |
| 4 | Feb. 17, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 17, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 17, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 17, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 17, 2026 | PRIMARY DOCUMENT | View Document |
| S-8 | Feb. 12, 2026 | S-8 | View Document |
| 10-K | Feb. 12, 2026 | 10-K | View Document |
| 8-K | Feb. 12, 2026 | 8-K | View Document |
| 4 | Jan. 14, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 14, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 14, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 14, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 14, 2026 | PRIMARY DOCUMENT | View Document |
| 144 | Jan. 13, 2026 | - | View Document |
| 8-K | Jan. 12, 2026 | 8-K | View Document |
| 3 | Jan. 7, 2026 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 7, 2026 | PRIMARY DOCUMENT | View Document |
| 8-K | Dec. 11, 2025 | 8-K | View Document |
| 8-K | Dec. 3, 2025 | 8-K | View Document |
| 4 | Dec. 1, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Nov. 17, 2025 | - | View Document |
| 4 | Nov. 14, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Nov. 12, 2025 | - | View Document |
| SCHEDULE 13G/A | Nov. 5, 2025 | - | View Document |
| 10-Q | Oct. 30, 2025 | 10-Q | View Document |
| 8-K | Oct. 30, 2025 | 8-K | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 3, 2025 | 8-K | View Document |
| 144 | Oct. 3, 2025 | - | View Document |
| 3 | Sept. 22, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | Sept. 12, 2025 | 8-K | View Document |
| 4 | Sept. 11, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | Sept. 10, 2025 | 8-K | View Document |
| 144 | Sept. 9, 2025 | - | View Document |
| 4 | Sept. 2, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 29, 2025 | - | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 19, 2025 | - | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 19, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 18, 2025 | - | View Document |
| 4 | Aug. 15, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 14, 2025 | - | View Document |
| 8-K | July 31, 2025 | 8-K | View Document |
| 10-Q | July 31, 2025 | 10-Q | View Document |
| 4 | July 2, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | June 18, 2025 | 8-K | View Document |
| UPLOAD | June 17, 2025 | - | View Document |
| 4 | June 3, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | June 2, 2025 | - | View Document |
| 144 | May 30, 2025 | - | View Document |
| 144 | May 30, 2025 | - | View Document |
| CORRESP | May 22, 2025 | - | View Document |
| 4 | May 19, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | May 15, 2025 | - | View Document |
| 8-K | May 13, 2025 | 8-K | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | May 12, 2025 | PRIMARY DOCUMENT | View Document |
| UPLOAD | May 9, 2025 | - | View Document |
| 4 | May 6, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | May 1, 2025 | 8-K | View Document |
| 10-Q | May 1, 2025 | 10-Q | View Document |
| SCHEDULE 13G/A | April 7, 2025 | - | View Document |
| DEFA14A | April 4, 2025 | DEFA14A | View Document |
| 4 | March 25, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 25, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | March 24, 2025 | - | View Document |
| 144 | March 24, 2025 | - | View Document |
| ARS | March 24, 2025 | ARS | View Document |
| DEFA14A | March 24, 2025 | DEFA14A | View Document |
| DEF 14A | March 24, 2025 | DEF 14A | View Document |
| 8-K | March 21, 2025 | 8-K | View Document |
| 144 | March 21, 2025 | - | View Document |
| PRE 14A | March 14, 2025 | PRE 14A | View Document |
| 4 | March 14, 2025 | PRIMARY DOCUMENT | View Document |
| 8-K | March 5, 2025 | 8-K | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | March 4, 2025 | - | View Document |
| 144 | March 4, 2025 | - | View Document |
| 4 | March 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 3, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | March 3, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | March 3, 2025 | - | View Document |
| 144 | March 3, 2025 | - | View Document |
| 4 | Feb. 18, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 18, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 18, 2025 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 18, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 144 | Feb. 18, 2025 | - | View Document |
| 10-K | Feb. 13, 2025 | 10-K | View Document |
| SCHEDULE 13G | Feb. 13, 2025 | - | View Document |
| 8-K | Feb. 13, 2025 | 8-K | View Document |
| 4 | Jan. 29, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Jan. 27, 2025 | - | View Document |
| 4 | Jan. 24, 2025 | PRIMARY DOCUMENT | View Document |
| 144 | Jan. 23, 2025 | - | View Document |
| 8-K | Jan. 13, 2025 | 8-K | View Document |
| 4 | Dec. 13, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | Dec. 12, 2024 | - | View Document |
| 4 | Nov. 27, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 27, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 27, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 27, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 27, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | Nov. 27, 2024 | - | View Document |
| SC 13G/A | Nov. 12, 2024 | - | View Document |
| SC 13G/A | Nov. 8, 2024 | SEC SCHEDULE 13G | View Document |
| 10-Q | Oct. 31, 2024 | 10-Q | View Document |
| 8-K | Oct. 31, 2024 | 8-K | View Document |
| 4 | Oct. 10, 2024 | PRIMARY DOCUMENT | View Document |
| 3 | Oct. 3, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2024 | PRIMARY DOCUMENT | View Document |
| UPLOAD | Sept. 25, 2024 | - | View Document |
| 4 | Aug. 22, 2024 | PRIMARY DOCUMENT | View Document |
| CORRESP | Aug. 22, 2024 | - | View Document |
| 144 | Aug. 20, 2024 | - | View Document |
| 4 | Aug. 14, 2024 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Aug. 12, 2024 | - | View Document |
| 144 | Aug. 12, 2024 | - | View Document |
| UPLOAD | Aug. 12, 2024 | - | View Document |
| 4 | Aug. 8, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 6, 2024 | - | View Document |
| 4 | Aug. 2, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 1, 2024 | - | View Document |
| 10-Q | Aug. 1, 2024 | 10-Q | View Document |
| 8-K | Aug. 1, 2024 | 8-K | View Document |
| 4 | July 12, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | July 11, 2024 | - | View Document |
| SC 13G/A | July 5, 2024 | - | View Document |
| 4 | June 27, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | June 26, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | June 25, 2024 | - | View Document |
| 144 | June 24, 2024 | - | View Document |
| 4 | May 31, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | May 29, 2024 | - | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 8-K | May 20, 2024 | 8-K | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2024 | PRIMARY DOCUMENT | View Document |
| 10-Q | May 2, 2024 | 10-Q | View Document |
| 8-K | May 2, 2024 | 8-K | View Document |
| DEF 14A | April 1, 2024 | DEF 14A | View Document |
| DEFA14A | April 1, 2024 | DEFA14A | View Document |
| ARS | April 1, 2024 | ARS | View Document |
| 3 | March 28, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2024 | PRIMARY DOCUMENT | View Document |
| 8-K | March 4, 2024 | 8-K | View Document |
| 4 | March 1, 2024 | PRIMARY DOCUMENT | View Document |
| 144 | Feb. 29, 2024 | - | View Document |
| 4 | Feb. 29, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 29, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 29, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 29, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 29, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 20, 2024 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 20, 2024 | PRIMARY DOCUMENT | View Document |
| 10-K | Feb. 15, 2024 | 10-K | View Document |
| 8-K | Feb. 15, 2024 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 13, 2024 | SCHEDULE 13G/A | View Document |
| SC 13G/A | Feb. 9, 2024 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 9, 2024 | - | View Document |
| SC 13G/A | Feb. 9, 2024 | SEC SCHEDULE 13G | View Document |
| 4 | Feb. 5, 2024 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Jan. 29, 2024 | - | View Document |
| SC 13G/A | Jan. 26, 2024 | - | View Document |
| 8-K | Jan. 19, 2024 | 8-K | View Document |
| 8-K | Jan. 8, 2024 | FORM 8-K | View Document |
| 4 | Dec. 29, 2023 | PRIMARY DOCUMENT | View Document |
| 144 | Dec. 27, 2023 | - | View Document |
| 144 | Dec. 11, 2023 | - | View Document |
| 8-K | Nov. 2, 2023 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Nov. 2, 2023 | 10-Q | View Document |
| 8-K | Oct. 10, 2023 | 8-K | View Document |
| 8-K | Sept. 28, 2023 | 8-K | View Document |
| 4 | Aug. 7, 2023 | PRIMARY DOCUMENT | View Document |
| 144 | Aug. 7, 2023 | - | View Document |
| 4 | Aug. 7, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 4, 2023 | PRIMARY DOCUMENT | View Document |
| 10-Q | Aug. 3, 2023 | 10-Q | View Document |
| 8-K | Aug. 3, 2023 | 8-K | View Document |
| 8-K | July 26, 2023 | 8-K | View Document |
| 8-K | June 30, 2023 | 8-K | View Document |
| 8-K | May 23, 2023 | 8-K | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | May 19, 2023 | PRIMARY DOCUMENT | View Document |
| 8-K | May 4, 2023 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | May 4, 2023 | 10-Q | View Document |
| 4 | April 28, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | April 28, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | April 28, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | April 28, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | April 28, 2023 | PRIMARY DOCUMENT | View Document |
| 144 | April 28, 2023 | - | View Document |
| 4 | April 10, 2023 | PRIMARY DOCUMENT | View Document |
| DEF 14A | April 3, 2023 | DEF 14A | View Document |
| DEFA14A | April 3, 2023 | DEFA14A | View Document |
| ARS | April 3, 2023 | ARS | View Document |
| 3 | March 9, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 9, 2023 | PRIMARY DOCUMENT | View Document |
| 8-K | March 8, 2023 | 8-K | View Document |
| 4 | March 7, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2023 | PRIMARY DOCUMENT | View Document |
| 8-K | Feb. 23, 2023 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-K | Feb. 23, 2023 | 10-K | View Document |
| S-8 | Feb. 23, 2023 | S-8 | View Document |
| SC 13G/A | Feb. 14, 2023 | - | View Document |
| CT ORDER | Feb. 14, 2023 | - | View Document |
| 4 | Feb. 14, 2023 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 13, 2023 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 9, 2023 | SCHEDULE 13G/A | View Document |
| SC 13G/A | Feb. 9, 2023 | - | View Document |
| SC 13G/A | Feb. 6, 2023 | SEC SCHEDULE 13G | View Document |
| 4 | Feb. 3, 2023 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2023 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Jan. 31, 2023 | - | View Document |
| SC 13G/A | Jan. 19, 2023 | - | View Document |
| 3 | Jan. 9, 2023 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 9, 2023 | FORM 8-K | View Document |
| 4 | Jan. 9, 2023 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 6, 2023 | 8-K | View Document |
| 4 | Dec. 7, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 23, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 27, 2022 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Oct. 27, 2022 | 10-Q | View Document |
| 8-K | Sept. 16, 2022 | 8-K | View Document |
| 8-K | Sept. 13, 2022 | 8-K | View Document |
| SC 13G | Sept. 9, 2022 | SEC SCHEDULE 13G | View Document |
| 8-K | Aug. 24, 2022 | 8-K | View Document |
| 3 | Aug. 24, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 24, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 17, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 5, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 5, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 5, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 5, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 5, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | July 28, 2022 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | July 28, 2022 | 10-Q | View Document |
| 4 | July 7, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | June 14, 2022 | 8-K | View Document |
| 8-K | May 23, 2022 | 8-K | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | May 20, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | April 28, 2022 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | April 28, 2022 | 10-Q | View Document |
| 8-K | April 5, 2022 | 8-K | View Document |
| DEF 14A | April 5, 2022 | DEF 14A | View Document |
| DEFA14A | April 5, 2022 | DEFA14A | View Document |
| 4 | April 5, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | April 4, 2022 | 8-K | View Document |
| 8-K | March 17, 2022 | 8-K | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 25, 2022 | PRIMARY DOCUMENT | View Document |
| SC 13G | Feb. 14, 2022 | - | View Document |
| 4 | Feb. 11, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | Feb. 10, 2022 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-K | Feb. 10, 2022 | 10-K | View Document |
| 4 | Feb. 9, 2022 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 9, 2022 | - | View Document |
| 3 | Feb. 9, 2022 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 9, 2022 | SCHEDULE 13G/A | View Document |
| SC 13G/A | Feb. 4, 2022 | SEC SCHEDULE 13G | View Document |
| 4 | Feb. 3, 2022 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 3, 2022 | - | View Document |
| SC 13G/A | Jan. 18, 2022 | - | View Document |
| 8-K | Jan. 10, 2022 | 8-K | View Document |
| 3 | Jan. 4, 2022 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 4, 2022 | 8-K | View Document |
| 4 | Jan. 4, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 4, 2022 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 23, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 23, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 23, 2021 | PRIMARY DOCUMENT | View Document |
| 8-K | Dec. 20, 2021 | 8-K | View Document |
| 4 | Dec. 14, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 12, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 29, 2021 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 28, 2021 | 8-K | View Document |
| 10-Q | Oct. 28, 2021 | 10-Q | View Document |
| 8-K | Sept. 8, 2021 | 8-K | View Document |
| 4 | Aug. 16, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 11, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 9, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 9, 2021 | PRIMARY DOCUMENT | View Document |
| 10-Q | Aug. 3, 2021 | 10-Q | View Document |
| 8-K | Aug. 3, 2021 | 8-K | View Document |
| 4 | Aug. 3, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 19, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | July 14, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | June 11, 2021 | PRIMARY DOCUMENT | View Document |
| 8-K | May 21, 2021 | 8-K | View Document |
| 4 | May 17, 2021 | PRIMARY DOCUMENT | View Document |
| 10-Q | April 29, 2021 | 10-Q | View Document |
| 8-K | April 29, 2021 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | April 21, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | April 21, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | April 21, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | April 21, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | April 21, 2021 | PRIMARY DOCUMENT | View Document |
| 8-K | April 12, 2021 | 8-K | View Document |
| DEFA14A | April 2, 2021 | DEFA14A | View Document |
| DEF 14A | April 2, 2021 | DEF 14A | View Document |
| SEC STAFF LETTER | March 18, 2021 | - | View Document |
| 3 | March 10, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 26, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 26, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 26, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 26, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 26, 2021 | PRIMARY DOCUMENT | View Document |
| SEC STAFF LETTER | Feb. 18, 2021 | - | View Document |
| 4 | Feb. 16, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 16, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 16, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 16, 2021 | PRIMARY DOCUMENT | View Document |
| S-8 | Feb. 11, 2021 | S-8 | View Document |
| 10-K | Feb. 11, 2021 | 10-K | View Document |
| 8-K | Feb. 11, 2021 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 10, 2021 | SCHEDULE 13G/A | View Document |
| SC 13G/A | Feb. 8, 2021 | - | View Document |
| SC 13G/A | Feb. 3, 2021 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 1, 2021 | - | View Document |
| SC 13G/A | Jan. 29, 2021 | - | View Document |
| 4 | Jan. 15, 2021 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Jan. 14, 2021 | - | View Document |
| 4 | Jan. 13, 2021 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 13, 2021 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 11, 2021 | 8-K | View Document |
| 4 | Dec. 22, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 30, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 20, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | Nov. 5, 2020 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Nov. 5, 2020 | 10-Q | View Document |
| 8-K | Oct. 2, 2020 | 8-K | View Document |
| 4 | Oct. 1, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 11, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 21, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 20, 2020 | 8-K | View Document |
| 4 | Aug. 11, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 6, 2020 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Aug. 6, 2020 | 10-Q | View Document |
| 4 | July 14, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 14, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 10, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 9, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | July 6, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | June 24, 2020 | PRIMARY DOCUMENT | View Document |
| S-3ASR | June 5, 2020 | S-3ASR | View Document |
| 4 | May 22, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | May 11, 2020 | 8-K | View Document |
| 4 | May 7, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | May 7, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | May 6, 2020 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | May 6, 2020 | 10-Q | View Document |
| 4 | April 22, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | April 22, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | April 13, 2020 | 8-K | View Document |
| 4 | April 9, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | April 9, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | April 9, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | April 9, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | April 9, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | April 6, 2020 | 8-K | View Document |
| DEFA14A | March 24, 2020 | DEFA14A | View Document |
| DEF 14A | March 23, 2020 | DEF 14A | View Document |
| 3 | March 4, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | March 4, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 28, 2020 | PRIMARY DOCUMENT | View Document |
| 8-K | Feb. 27, 2020 | 8-K | View Document |
| 4 | Feb. 21, 2020 | PRIMARY DOCUMENT | View Document |
| 10-K | Feb. 13, 2020 | 10-K | View Document |
| 4 | Feb. 13, 2020 | PRIMARY DOCUMENT | View Document |
| S-8 | Feb. 13, 2020 | S-8 | View Document |
| 4/A | Feb. 12, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 12, 2020 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 12, 2020 | SCHEDULE 13G/A | View Document |
| SC 13G/A | Feb. 12, 2020 | SCHEDULE 13G/A | View Document |
| 4 | Feb. 11, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 11, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 11, 2020 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 7, 2020 | - | View Document |
| 8-K | Feb. 6, 2020 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 5, 2020 | - | View Document |
| SC 13G | Feb. 3, 2020 | - | View Document |
| 4 | Jan. 31, 2020 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 29, 2020 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Jan. 28, 2020 | SEC SCHEDULE 13G | View Document |
| 8-K | Jan. 13, 2020 | 8-K | View Document |
| 4 | Dec. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 13, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 26, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 22, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 22, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | Nov. 20, 2019 | 8-K | View Document |
| 4 | Nov. 20, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 31, 2019 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Oct. 31, 2019 | 10-Q | View Document |
| 4 | Oct. 24, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 16, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 3, 2019 | 8-K | View Document |
| 3 | Aug. 13, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 7, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 6, 2019 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Aug. 6, 2019 | 10-Q | View Document |
| 8-K | July 11, 2019 | FORM 8-K | View Document |
| CT ORDER | July 5, 2019 | - | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | July 2, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | May 21, 2019 | 8-K | View Document |
| 4 | May 17, 2019 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | May 3, 2019 | SC 13G/A | View Document |
| CT ORDER | May 2, 2019 | - | View Document |
| CT ORDER | May 2, 2019 | - | View Document |
| 10-Q | May 2, 2019 | MARCH 31, 2019 FORM 10-Q | View Document |
| CT ORDER | May 2, 2019 | - | View Document |
| 8-K | May 1, 2019 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 8-K | April 26, 2019 | 8-K | View Document |
| 4 | April 17, 2019 | PRIMARY DOCUMENT | View Document |
| DEFA14A | April 10, 2019 | DEFA14A | View Document |
| CT ORDER | April 10, 2019 | - | View Document |
| 8-K | April 9, 2019 | 8-K | View Document |
| DEFA14A | April 8, 2019 | DEFA14A | View Document |
| UPLOAD | March 21, 2019 | - | View Document |
| DEF 14A | March 21, 2019 | DEF 14A | View Document |
| PRER14A | March 18, 2019 | PRER14A | View Document |
| PRE 14A | March 11, 2019 | PRE 14A | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | March 1, 2019 | PRIMARY DOCUMENT | View Document |
| 10-K | Feb. 14, 2019 | 10-K | View Document |
| SC 13G/A | Feb. 14, 2019 | - | View Document |
| SC 13G/A | Feb. 14, 2019 | SCHEDULE 13G AMENDMENT 3 | View Document |
| SC 13G/A | Feb. 13, 2019 | - | View Document |
| SC 13G/A | Feb. 12, 2019 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 11, 2019 | - | View Document |
| 8-K | Feb. 7, 2019 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 4, 2019 | - | View Document |
| SC 13G/A | Jan. 31, 2019 | - | View Document |
| 4 | Jan. 22, 2019 | FORM 4 SUBMISSION | View Document |
| 8-K | Jan. 15, 2019 | 8-K | View Document |
| 424B5 | Jan. 15, 2019 | 424B5 | View Document |
| 424B5 | Jan. 14, 2019 | 424B5 | View Document |
| 3 | Jan. 11, 2019 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 11, 2019 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 7, 2019 | 8-K | View Document |
| 8-K | Dec. 10, 2018 | 8-K | View Document |
| 4 | Nov. 26, 2018 | PRIMARY DOCUMENT | View Document |
| 10-Q | Nov. 7, 2018 | Q3 2018 FORM 10-Q | View Document |
| 8-K | Nov. 7, 2018 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 8-K | Oct. 10, 2018 | 8-K | View Document |
| 8-K | Oct. 2, 2018 | 8-K | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 28, 2018 | PRIMARY DOCUMENT | View Document |
| CT ORDER | Sept. 12, 2018 | - | View Document |
| 4 | Sept. 4, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 23, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 23, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 23, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 23, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 23, 2018 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 17, 2018 | 8-K | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 14, 2018 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 10, 2018 | FORM 8-K | View Document |
| S-8 POS | Aug. 2, 2018 | S-8 POS | View Document |
| S-8 POS | Aug. 2, 2018 | S-8 POS | View Document |
| S-8 POS | Aug. 2, 2018 | S-8 POS | View Document |
| S-8 POS | Aug. 2, 2018 | S-8 POS | View Document |
| S-8 | Aug. 2, 2018 | S-8 | View Document |
| 10-Q | Aug. 2, 2018 | Q2 2018 FORM 10-Q | View Document |
| 8-K | Aug. 2, 2018 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | July 27, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 22, 2018 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | June 11, 2018 | - | View Document |
| CT ORDER | June 5, 2018 | - | View Document |
| 4 | June 4, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | June 4, 2018 | PRIMARY DOCUMENT | View Document |
| 3 | June 4, 2018 | PRIMARY DOCUMENT | View Document |
| 8-K | May 15, 2018 | 8-K | View Document |
| SC 13G/A | May 10, 2018 | SEC SCHEDULE 13G | View Document |
| 10-Q | May 4, 2018 | Q1'18 10-Q | View Document |
| 8-K | May 3, 2018 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 8-K | April 20, 2018 | 8-K | View Document |
| 8-K | April 3, 2018 | 8-K | View Document |
| 4 | March 28, 2018 | PRIMARY DOCUMENT | View Document |
| DEF 14A | March 23, 2018 | DEF 14A | View Document |
| 4 | March 22, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 16, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 16, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 14, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 14, 2018 | PRIMARY DOCUMENT | View Document |
| 8-K | March 14, 2018 | FORM 8-K | View Document |
| 4 | March 13, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | March 5, 2018 | PRIMARY DOCUMENT | View Document |
| 10-K | Feb. 15, 2018 | 10-K | View Document |
| SC 13G/A | Feb. 14, 2018 | - | View Document |
| SC 13G/A | Feb. 13, 2018 | SC 13G/A | View Document |
| SC 13G/A | Feb. 13, 2018 | - | View Document |
| SC 13G/A | Feb. 12, 2018 | - | View Document |
| 5 | Feb. 9, 2018 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 9, 2018 | SCHEDULE 13G AMENDMENT NO 2 | View Document |
| SC 13G/A | Feb. 8, 2018 | - | View Document |
| SC 13G/A | Feb. 8, 2018 | SEC SCHEDULE 13G | View Document |
| 8-K | Feb. 8, 2018 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 2, 2018 | - | View Document |
| CT ORDER | Jan. 24, 2018 | - | View Document |
| CT ORDER | Jan. 24, 2018 | - | View Document |
| UPLOAD | Jan. 23, 2018 | - | View Document |
| CORRESP | Jan. 19, 2018 | - | View Document |
| UPLOAD | Jan. 10, 2018 | - | View Document |
| 8-K | Jan. 8, 2018 | 8-K | View Document |
| 4 | Jan. 8, 2018 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 3, 2018 | FORM 8-K | View Document |
| 4 | Jan. 3, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2018 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 21, 2017 | PRIMARY DOCUMENT | View Document |
| SC 13G | Dec. 11, 2017 | ALNY AS OF 11/30/2017 | View Document |
| CORRESP | Dec. 11, 2017 | - | View Document |
| 4 | Dec. 5, 2017 | PRIMARY DOCUMENT | View Document |
| UPLOAD | Nov. 28, 2017 | - | View Document |
| 4 | Nov. 24, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 17, 2017 | PRIMARY DOCUMENT | View Document |
| 424B5 | Nov. 14, 2017 | 424B5 | View Document |
| 8-K | Nov. 14, 2017 | FORM 8-K | View Document |
| 424B5 | Nov. 13, 2017 | 424(B)(5) | View Document |
| 4 | Nov. 8, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 8, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 8, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 8, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 8, 2017 | PRIMARY DOCUMENT | View Document |
| 10-Q | Nov. 7, 2017 | Q3'17 FORM 10-Q | View Document |
| 8-K | Nov. 7, 2017 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | Nov. 3, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 1, 2017 | PRIMARY DOCUMENT | View Document |
| CT ORDER | Oct. 24, 2017 | - | View Document |
| 4 | Oct. 4, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 22, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 22, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 22, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 22, 2017 | PRIMARY DOCUMENT | View Document |
| CT ORDER | Sept. 12, 2017 | - | View Document |
| 8-K | Sept. 7, 2017 | 8-K | View Document |
| 8-K | Aug. 9, 2017 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| S-8 | Aug. 9, 2017 | FORM S-8 | View Document |
| 10-Q | Aug. 9, 2017 | 10-Q | View Document |
| SC 13G/A | Aug. 9, 2017 | SC 13G/A | View Document |
| 4 | July 11, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | July 11, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | July 11, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | July 11, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | July 11, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 15, 2017 | PRIMARY DOCUMENT | View Document |
| 8-K | June 6, 2017 | FORM 8-K | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | June 1, 2017 | FORM 4 SUBMISSION | View Document |
| 4 | May 31, 2017 | PRIMARY DOCUMENT | View Document |
| 8-K | May 25, 2017 | 8-K | View Document |
| 424B5 | May 25, 2017 | 424B5 | View Document |
| 4 | May 25, 2017 | PRIMARY DOCUMENT | View Document |
| 424B5 | May 23, 2017 | 424B5 | View Document |
| 4 | May 17, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | May 17, 2017 | PRIMARY DOCUMENT | View Document |
| 3 | May 9, 2017 | PRIMARY DOCUMENT | View Document |
| 8-K | May 9, 2017 | FORM 8-K | View Document |
| S-3ASR | May 5, 2017 | S-3ASR | View Document |
| 8-K | May 5, 2017 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | May 5, 2017 | 10-Q | View Document |
| DEF 14A | March 17, 2017 | DEFINITIVE PROXY STATEMENT | View Document |
| 10-K | Feb. 15, 2017 | 10-K | View Document |
| SC 13G/A | Feb. 14, 2017 | SCHEDULE 13G AMENDMENT NO. 1 | View Document |
| SC 13G/A | Feb. 14, 2017 | - | View Document |
| SC 13G/A | Feb. 13, 2017 | - | View Document |
| SC 13G/A | Feb. 13, 2017 | SC 13G/A | View Document |
| SC 13G/A | Feb. 9, 2017 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 9, 2017 | - | View Document |
| 8-K | Feb. 8, 2017 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| CT ORDER | Feb. 7, 2017 | - | View Document |
| 4 | Feb. 3, 2017 | PRIMARY DOCUMENT | View Document |
| SC 13G | Jan. 30, 2017 | - | View Document |
| 4 | Jan. 27, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 20, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 6, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 4, 2017 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2017 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 3, 2017 | 8-K | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 14, 2016 | PRIMARY DOCUMENT | View Document |
| SC 13G | Dec. 9, 2016 | SCHEDULE 13G | View Document |
| SC 13G/A | Dec. 9, 2016 | - | View Document |
| 4 | Dec. 5, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 2, 2016 | PRIMARY DOCUMENT | View Document |
| 10-Q | Nov. 3, 2016 | FORM 10-Q | View Document |
| 8-K | Nov. 2, 2016 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | Oct. 14, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 14, 2016 | PRIMARY DOCUMENT | View Document |
| 8-K | Oct. 5, 2016 | 8-K | View Document |
| 3 | Sept. 21, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 21, 2016 | PRIMARY DOCUMENT | View Document |
| 8-K | Sept. 19, 2016 | FORM 8-K | View Document |
| 10-Q | Aug. 4, 2016 | FORM 10-Q | View Document |
| 8-K | Aug. 4, 2016 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | July 21, 2016 | PRIMARY DOCUMENT | View Document |
| 8-K | June 15, 2016 | FORM 8-K | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | June 7, 2016 | PRIMARY DOCUMENT | View Document |
| CT ORDER | May 19, 2016 | - | View Document |
| 8-K | May 6, 2016 | FORM 8-K | View Document |
| 10-Q | May 4, 2016 | 10-Q | View Document |
| 8-K | May 2, 2016 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | April 21, 2016 | PRIMARY DOCUMENT | View Document |
| 8-K | April 8, 2016 | FORM 8-K | View Document |
| CT ORDER | April 4, 2016 | - | View Document |
| 4 | March 28, 2016 | PRIMARY DOCUMENT | View Document |
| DEF 14A | March 17, 2016 | DEF 14A | View Document |
| 4 | March 10, 2016 | PRIMARY DOCUMENT | View Document |
| CT ORDER | March 9, 2016 | - | View Document |
| SC 13G/A | March 1, 2016 | SCHEDULE 13G/A | View Document |
| 4 | Feb. 25, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 24, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 24, 2016 | FORM 4 SUBMISSION | View Document |
| 10-K | Feb. 12, 2016 | FORM 10-K | View Document |
| SC 13G/A | Feb. 12, 2016 | SC 13G/A | View Document |
| SC 13G/A | Feb. 12, 2016 | - | View Document |
| SC 13G/A | Feb. 11, 2016 | SEC SCHEDULE 13G | View Document |
| 8-K | Feb. 11, 2016 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G | Feb. 10, 2016 | - | View Document |
| SC 13G/A | Feb. 9, 2016 | - | View Document |
| 4 | Feb. 3, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2016 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 3, 2016 | FORM 4 SUBMISSION | View Document |
| SC 13G | Jan. 28, 2016 | - | View Document |
| 4 | Jan. 21, 2016 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 11, 2016 | 8-K | View Document |
| UPLOAD | Dec. 23, 2015 | - | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 3 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | Dec. 22, 2015 | FORM 8-K | View Document |
| 8-K | Dec. 18, 2015 | FORM 8-K | View Document |
| CORRESP | Dec. 9, 2015 | - | View Document |
| 4 | Dec. 9, 2015 | PRIMARY DOCUMENT | View Document |
| CT ORDER | Dec. 8, 2015 | - | View Document |
| 4 | Dec. 4, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 4, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 30, 2015 | PRIMARY DOCUMENT | View Document |
| UPLOAD | Nov. 25, 2015 | - | View Document |
| 4 | Nov. 20, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 13, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | Nov. 9, 2015 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 10-Q | Nov. 9, 2015 | FORM 10-Q | View Document |
| CT ORDER | Oct. 5, 2015 | - | View Document |
| S-8 | Oct. 2, 2015 | S-8 | View Document |
| 8-K | Oct. 2, 2015 | FORM 8-K | View Document |
| 10-Q | Aug. 7, 2015 | FORM 10-Q | View Document |
| 4 | Aug. 6, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | Aug. 6, 2015 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 15-12B | Aug. 6, 2015 | 15-12B | View Document |
| 25 | July 27, 2015 | FORM 25 | View Document |
| 8-K | July 14, 2015 | FORM 8-K | View Document |
| 8-K | July 10, 2015 | FORM 8-K | View Document |
| 4 | June 18, 2015 | PRIMARY DOCUMENT | View Document |
| 3 | June 10, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | June 10, 2015 | 8-K | View Document |
| 4 | June 10, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | June 3, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 28, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 13, 2015 | PRIMARY DOCUMENT | View Document |
| 10-Q | May 8, 2015 | FORM 10-Q | View Document |
| 8-K | May 7, 2015 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 8-K | May 5, 2015 | FORM 8-K | View Document |
| 4 | May 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | May 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | April 23, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | April 23, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | April 6, 2015 | FORM 8-K | View Document |
| 4 | March 19, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | March 19, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | March 19, 2015 | PRIMARY DOCUMENT | View Document |
| ARS | March 16, 2015 | AUTO-GENERATED PAPER DOCUMENT | View Document |
| DEF 14A | March 10, 2015 | DEF 14A | View Document |
| 4 | March 6, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 27, 2015 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 13, 2015 | - | View Document |
| 10-K | Feb. 13, 2015 | FORM 10-K | View Document |
| SC 13G/A | Feb. 12, 2015 | ALNY AS OF 12/31/2014 | View Document |
| SC 13G/A | Feb. 12, 2015 | SEC SCHEDULE 13G | View Document |
| SC 13G/A | Feb. 12, 2015 | SCHEDULE 13G AMENDMENT NO. 1 | View Document |
| 8-K | Feb. 12, 2015 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G/A | Feb. 6, 2015 | - | View Document |
| 8-K | Feb. 3, 2015 | FORM 8-K | View Document |
| 4/A | Feb. 2, 2015 | 4/A | View Document |
| SC 13G/A | Feb. 2, 2015 | SC 13G/A | View Document |
| 4 | Feb. 2, 2015 | 4 | View Document |
| 4 | Jan. 28, 2015 | 4 | View Document |
| 4 | Jan. 28, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 28, 2015 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 26, 2015 | FORM 8-K | View Document |
| 424B5 | Jan. 21, 2015 | 424B5 | View Document |
| 424B5 | Jan. 20, 2015 | 424B5 | View Document |
| 8-K | Jan. 14, 2015 | 8-K | View Document |
| 10-Q/A | Jan. 9, 2015 | FORM 10-Q AMENDMENT NO. 1 | View Document |
| 8-K | Jan. 8, 2015 | 8-K | View Document |
| 4 | Jan. 5, 2015 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 22, 2014 | PRIMARY DOCUMENT | View Document |
| 8-K | Dec. 19, 2014 | 8-K | View Document |
| 4 | Dec. 18, 2014 | PRIMARY DOCUMENT | View Document |
| 3 | Dec. 18, 2014 | PRIMARY DOCUMENT | View Document |
| 8-K | Dec. 18, 2014 | 8-K | View Document |
| 4 | Dec. 16, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 16, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 16, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 16, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 16, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 10, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 10, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 19, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 19, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 13, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Nov. 13, 2014 | PRIMARY DOCUMENT | View Document |
| 10-Q | Nov. 6, 2014 | 10-Q | View Document |
| 8-K | Nov. 5, 2014 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 4 | Oct. 30, 2014 | PRIMARY DOCUMENT | View Document |
| 4/A | Oct. 28, 2014 | FORM 4/A SUBMISSION | View Document |
| 4 | Oct. 24, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 24, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Oct. 17, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Oct. 15, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 10, 2014 | FORM 4 SUBMISSION | View Document |
| 3 | Oct. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Oct. 3, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Sept. 26, 2014 | FORM 4 SUBMISSION | View Document |
| 8-K | Sept. 26, 2014 | FORM 8-K | View Document |
| 4 | Sept. 26, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 19, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Sept. 19, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 17, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Sept. 12, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Sept. 5, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Aug. 29, 2014 | FORM 4 SUBMISSION | View Document |
| ARS | Aug. 26, 2014 | AUTO-GENERATED PAPER DOCUMENT | View Document |
| 4 | Aug. 22, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | Aug. 20, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Aug. 15, 2014 | FORM 4 SUBMISSION | View Document |
| 10-Q | Aug. 8, 2014 | FORM 10-Q | View Document |
| 4 | Aug. 8, 2014 | FORM 4 SUBMISSION | View Document |
| 8-K | Aug. 7, 2014 | ALNYLAM PHARMACEUTICALS 8-K | View Document |
| 4 | Aug. 1, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | July 25, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | July 18, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | July 11, 2014 | FORM 4 SUBMISSION | View Document |
| SC 13G/A | July 10, 2014 | - | View Document |
| 4 | July 7, 2014 | FORM 4 SUBMISSION | View Document |
| 8-K | July 2, 2014 | FORM 8-K | View Document |
| 4 | July 2, 2014 | PRIMARY DOCUMENT | View Document |
| 3 | July 2, 2014 | PRIMARY DOCUMENT | View Document |
| CT ORDER | June 30, 2014 | - | View Document |
| 4 | June 27, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 27, 2014 | FORM 4 SUBMISSION | View Document |
| 4 | June 19, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | June 6, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | May 23, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | May 21, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | May 16, 2014 | PRIMARY DOCUMENT | View Document |
| 10-Q | May 9, 2014 | 10-Q | View Document |
| 8-K | May 8, 2014 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| DEF 14A | April 29, 2014 | DEF 14A | View Document |
| 4 | April 15, 2014 | PRIMARY DOCUMENT | View Document |
| 8-A12B | April 8, 2014 | 8-A12B | View Document |
| 8-K | April 2, 2014 | FORM 8-K | View Document |
| 4 | March 27, 2014 | 4 | View Document |
| 8-K | March 24, 2014 | FORM 8-K | View Document |
| 4 | March 20, 2014 | PRIMARY DOCUMENT | View Document |
| CT ORDER | March 7, 2014 | - | View Document |
| 8-K | March 6, 2014 | FORM 8-K | View Document |
| SC 13G | March 5, 2014 | SC 13G | View Document |
| 3 | March 3, 2014 | 3 | View Document |
| 8-K | Feb. 27, 2014 | FORM 8-K | View Document |
| 8-K | Feb. 26, 2014 | FORM 8-K | View Document |
| 4 | Feb. 25, 2014 | PRIMARY DOCUMENT | View Document |
| 10-K | Feb. 20, 2014 | 10-K | View Document |
| 4 | Feb. 20, 2014 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Feb. 14, 2014 | DISCLOSURE DOCUMENT | View Document |
| SC 13G/A | Feb. 14, 2014 | - | View Document |
| 8-K | Feb. 13, 2014 | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| SC 13G | Feb. 12, 2014 | ALNY AS OF 12/31/2013 | View Document |
| 4 | Feb. 4, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Feb. 4, 2014 | PRIMARY DOCUMENT | View Document |
| SC 13G | Feb. 4, 2014 | - | View Document |
| 4 | Feb. 4, 2014 | PRIMARY DOCUMENT | View Document |
| SC 13G/A | Jan. 28, 2014 | - | View Document |
| 4 | Jan. 27, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 27, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 27, 2014 | PRIMARY DOCUMENT | View Document |
| UPLOAD | Jan. 15, 2014 | - | View Document |
| 4 | Jan. 14, 2014 | PRIMARY DOCUMENT | View Document |
| 8-K | Jan. 13, 2014 | FORM 8-K | View Document |
| 8-K | Jan. 13, 2014 | FORM 8-K | View Document |
| 4 | Jan. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 3, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Jan. 2, 2014 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 23, 2013 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 18, 2013 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 18, 2013 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 18, 2013 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 18, 2013 | PRIMARY DOCUMENT | View Document |
| 4 | Dec. 18, 2013 | PRIMARY DOCUMENT | View Document |